Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XR-NTX for Rural Individuals With Opioid Use Disorder
NCT03447743Phase 1Completed
- Start
- Sep 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of naltrexone in opioid use disorder (OUD). Primary endpoint: Study Enrollment at 3 months. Started Sep 2019; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03447743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03447743.